UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE SERIES A-1 PREFERRED STOCK, CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	Redeemable Series A-1 Preferred Stock	Convertible And Redeemable Series A-2 Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income
Beginning balance at Dec. 31, 2019	$ (26,291)				$ 38,153	$ (64,404)	$ (40)
Beginning balance, shares at Dec. 31, 2019				8,370,107
Beginning balance at Dec. 31, 2019		$ 128,822
Beginning balance, shares at Dec. 31, 2019		12,000
Net income (loss)	(41,248)					(41,248)
Accretion of the redeemable series A-1 preferred stock to redeemable value	(5,415)				(5,415)
Accretion of the redeemable series A-1 preferred stock to redeemable shares		$ 5,415
Stock-based compensation	1,150				1,150
Accumulated other comprehensive income (loss)	37						37
Ending balance at Mar. 31, 2020	(71,767)				33,888	(105,652)	(3)
Ending balance, shares at Mar. 31, 2020		12,000
Ending balance at Mar. 31, 2020		$ 134,237
Ending balance, shares at Mar. 31, 2020				8,370,107
Beginning balance at Dec. 31, 2019	(26,291)				38,153	(64,404)	(40)
Beginning balance, shares at Dec. 31, 2019				8,370,107
Beginning balance at Dec. 31, 2019		$ 128,822
Beginning balance, shares at Dec. 31, 2019		12,000
Net income (loss)	(28,024)
Common stock issued	$ 25,021
Common stock issued, shares	794,639
Ending balance at Jun. 30, 2020	$ (38,116)				54,405	(92,428)	(93)
Ending balance, shares at Jun. 30, 2020		12,000	17,500
Ending balance at Jun. 30, 2020		$ 139,881	$ 152,928
Ending balance, shares at Jun. 30, 2020				9,164,746
Beginning balance at Mar. 31, 2020	(71,767)				33,888	(105,652)	(3)
Beginning balance, shares at Mar. 31, 2020				8,370,107
Beginning balance at Mar. 31, 2020		$ 134,237
Beginning balance, shares at Mar. 31, 2020		12,000
Net income (loss)	13,224					13,224
Accretion of the redeemable series A-1 preferred stock to redeemable value	5,644	$ (5,644)			5,644
Issuance of the convertible and redeemable series A-2 preferred stock			$ 152,928
Issuance of the convertible and redeemable series A-2 preferred stock, shares			17,500
Stock-based compensation	1,140				1,140
Common stock issued	$ 25,021				25,021
Common stock issued, shares	794,639			794,639
Accumulated other comprehensive income (loss)	$ (90)						(90)
Ending balance at Jun. 30, 2020	(38,116)				54,405	(92,428)	(93)
Ending balance, shares at Jun. 30, 2020		12,000	17,500
Ending balance at Jun. 30, 2020		$ 139,881	$ 152,928
Ending balance, shares at Jun. 30, 2020				9,164,746
Beginning balance at Dec. 31, 2020	137,145				259,427	(122,353)	71
Beginning balance, shares at Dec. 31, 2020				24,932,527
Beginning balance at Dec. 31, 2020			$ 152,928
Beginning balance, shares at Dec. 31, 2020			17,500
Net income (loss)	(11,596)					(11,596)
Stock-based compensation	1,805				1,805
Dividend payment to the Series A-2 preferred shareholders	(4,100)				(4,100)
Common stock issued	4,456				4,456
Common stock issued, shares				506,330
Accumulated other comprehensive income (loss)	29						29
Ending balance at Mar. 31, 2021	127,739				261,588	(133,949)	100
Ending balance, shares at Mar. 31, 2021			17,500
Ending balance at Mar. 31, 2021			$ 152,928
Ending balance, shares at Mar. 31, 2021				25,438,857
Beginning balance at Dec. 31, 2020	137,145				259,427	(122,353)	71
Beginning balance, shares at Dec. 31, 2020				24,932,527
Beginning balance at Dec. 31, 2020			$ 152,928
Beginning balance, shares at Dec. 31, 2020			17,500
Net income (loss)	(26,079)
Dividend payment to the Series A-2 preferred shareholders			$ (8,200)
Common stock issued	$ 31,916
Common stock issued, shares	1,175,661
Ending balance at Jun. 30, 2021	$ 139,061				287,365	(148,432)	128
Ending balance, shares at Jun. 30, 2021			17,500
Ending balance at Jun. 30, 2021			$ 152,928
Ending balance, shares at Jun. 30, 2021				26,108,188
Beginning balance at Mar. 31, 2021	127,739				261,588	(133,949)	100
Beginning balance, shares at Mar. 31, 2021				25,438,857
Beginning balance at Mar. 31, 2021			$ 152,928
Beginning balance, shares at Mar. 31, 2021			17,500
Net income (loss)	(14,483)					(14,483)
Stock-based compensation	2,417				2,417
Dividend payment to the Series A-2 preferred shareholders	(4,100)		$ (4,100)		(4,100)
Common stock issued	$ 27,460				27,460
Common stock issued, shares	669,331			669,331
Accumulated other comprehensive income (loss)	$ 28						28
Ending balance at Jun. 30, 2021	$ 139,061				$ 287,365	$ (148,432)	$ 128
Ending balance, shares at Jun. 30, 2021			17,500
Ending balance at Jun. 30, 2021			$ 152,928
Ending balance, shares at Jun. 30, 2021				26,108,188